Search Results
Dr Sarah Tasian: NGS Has Revolutionized Treating Children With AML
Dr Sarah Tasian Highlights Challenges With Improving Outcomes in Pediatric AML
Dr Sarah Tasian Highlights Exciting New Advances Coming to Pediatric AML
Dr Sarah Tasian Discusses Challenges to Overcome When New Therapies Come to Market for Pediatric AML
Immunotherapy for pediatric AML
Dr Lena Winestone on Understanding the Cause of Disparities in Pediatric AML in Order to Intervene
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias
Challenges in treating pediatric leukemias
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
Future directions for treating Ph-like ALL subtypes
Blinatumomab and inotuzumab in children with R/R B-ALL
Targeting TCF3-HLF−positive ALL
